NNOX
Nano-X Imaging Ltd.
Medical - Devices
Market Cap$115M
5Y Perf.-76.2%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
NNOX vs GEHC
Revenue, margins, valuation, and 5-year total return — side by side.
GEHC
GE HealthCare Technologies Inc.
Medical - Healthcare Information Services
Market Cap$27.90B
5Y Perf.+5.1%
NNOX vs GEHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | NNOX | GEHC |
|---|---|---|
| Industry | Medical - Devices | Medical - Healthcare Information Services |
| Market Cap | $115M | $27.90B |
| Revenue (TTM) | $12M | $19.95B |
| Net Income (TTM) | $-56M | $1.50B |
| Gross Margin | -98.8% | 42.5% |
| Operating Margin | -469.7% | 12.5% |
| Forward P/E | — | 12.4x |
| Total Debt | $7M | $10.00B |
| Cash & Equiv. | $39M | $4.51B |
NNOX vs GEHC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
NNOX
GEHC
| Stock | Dec 22 | May 26 | Return |
|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | 100 | 23.8 | -76.2% |
| GE HealthCare Techn… (GEHC) | 100 | 105.1 | +5.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NNOX vs GEHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: GEHC leads in 5 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Nano-X Imaging Ltd. is the stronger pick specifically for growth and revenue expansion. As sector peers, any of these can serve as alternatives in the same allocation.
NNOX
Nano-X Imaging Ltd.
The Growth Play
NNOX is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 13.9%, EPS growth 15.7%, 3Y rev CAGR 105.3%
- Lower volatility, beta 1.86, Low D/E 3.9%, current ratio 5.63x
- 13.9% revenue growth vs GEHC's 4.8%
Best for: growth exposure and sleep-well-at-night
GEHC
GE HealthCare Technologies Inc.
The Income Pick
GEHC carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 3 yrs, beta 1.37, yield 0.2%
- 2.9% 10Y total return vs NNOX's -96.1%
- Beta 1.37, yield 0.2%, current ratio 1.18x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | NNOX | 13.9% revenue growth vs GEHC's 4.8% |
| Quality / Margins | GEHC | 7.5% margin vs NNOX's -452.8% |
| Stability / Safety | GEHC | Beta 1.37 vs NNOX's 1.86 |
| Dividends | GEHC | 0.2% yield; 3-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | GEHC | -10.7% vs NNOX's -64.4% |
| Efficiency (ROA) | GEHC | 4.1% ROA vs NNOX's -31.6%, ROIC 13.3% vs -27.9% |
NNOX vs GEHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
NNOX vs GEHC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLGEHCLAGGINGNNOX
NNOXNano-X Imaging Ltd.
1leads
GEHCGE HealthCare Technol…
4leads
6 Total Categories
CATEGORYLEADERvs NNOXMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
GEHC4/6
Valuation MetricsMultiples, price ratios, and targets
NNOX2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
GEHC5/8
Total Returns1Y, 3Y, 5Y total returns with dividends
GEHC6/6
Risk & VolatilityBeta, volatility, and downside exposure
GEHC2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
GEHC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GEHC is the larger business by revenue, generating $20.0B annually — 1622.0x NNOX's $12M. GEHC is the more profitable business, keeping 7.5% of every revenue dollar as net income compared to NNOX's -4.5%. On growth, NNOX holds the edge at +13.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… |
|---|---|---|
| RevenueTrailing 12 months | $12M | $20.0B |
| EBITDAEarnings before interest/tax | -$46M | $3.3B |
| Net IncomeAfter-tax profit | -$56M | $1.5B |
| Free Cash FlowCash after capex | -$47M | $1.5B |
| Gross MarginGross profit ÷ Revenue | -98.8% | +42.5% |
| Operating MarginEBIT ÷ Revenue | -4.7% | +12.5% |
| Net MarginNet income ÷ Revenue | -4.5% | +7.5% |
| FCF MarginFCF ÷ Revenue | -3.8% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.7% | +7.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +8.7% | -30.9% |
GEHC leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
NNOX leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… |
|---|---|---|
| Market CapShares × price | $115M | $27.9B |
| Enterprise ValueMkt cap + debt − cash | $83M | $33.4B |
| Trailing P/EPrice ÷ TTM EPS | -1.93x | 13.48x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 19.78x |
| EV / EBITDAEnterprise value multiple | — | 10.00x |
| Price / SalesMarket cap ÷ Revenue | 10.20x | 1.35x |
| Price / BookPrice ÷ Book value/share | 0.55x | 2.66x |
| Price / FCFMarket cap ÷ FCF | — | 18.53x |
NNOX leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
GEHC leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
GEHC delivers a 14.4% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-36 for NNOX. NNOX carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEHC's 0.94x.
| Metric | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… |
|---|---|---|
| ROE (TTM)Return on equity | -35.5% | +14.4% |
| ROA (TTM)Return on assets | -31.6% | +4.1% |
| ROICReturn on invested capital | -27.9% | +13.3% |
| ROCEReturn on capital employed | -28.4% | +10.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.04x | 0.94x |
| Net DebtTotal debt minus cash | -$32M | $5.5B |
| Cash & Equiv.Liquid assets | $39M | $4.5B |
| Total DebtShort + long-term debt | $7M | $10.0B |
| Interest CoverageEBIT ÷ Interest expense | -379.29x | 5.35x |
GEHC leads this category, winning 5 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
GEHC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GEHC five years ago would be worth $10,293 today (with dividends reinvested), compared to $605 for NNOX. Over the past 12 months, GEHC leads with a -10.7% total return vs NNOX's -64.4%. The 3-year compound annual growth rate (CAGR) favors GEHC at -8.0% vs NNOX's -52.4% — a key indicator of consistent wealth creation.
| Metric | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… |
|---|---|---|
| YTD ReturnYear-to-date | -37.8% | -25.9% |
| 1-Year ReturnPast 12 months | -64.4% | -10.7% |
| 3-Year ReturnCumulative with dividends | -89.2% | -22.2% |
| 5-Year ReturnCumulative with dividends | -93.9% | +2.9% |
| 10-Year ReturnCumulative with dividends | -96.1% | +2.9% |
| CAGR (3Y)Annualised 3-year return | -52.4% | -8.0% |
GEHC leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
GEHC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GEHC is the less volatile stock with a 1.37 beta — it tends to amplify market swings less than NNOX's 1.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GEHC currently trades 68.3% from its 52-week high vs NNOX's 30.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.86x | 1.37x |
| 52-Week HighHighest price in past year | $5.86 | $89.77 |
| 52-Week LowLowest price in past year | $1.66 | $58.75 |
| % of 52W HighCurrent price vs 52-week peak | +30.0% | +68.3% |
| RSI (14)Momentum oscillator 0–100 | 38.5 | 32.1 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 4.3M |
GEHC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates NNOX as "Buy" and GEHC as "Buy". Consensus price targets imply 922.7% upside for NNOX (target: $18) vs 36.9% for GEHC (target: $84). GEHC is the only dividend payer here at 0.23% yield — a key consideration for income-focused portfolios.
| Metric | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $18.00 | $84.00 |
| # AnalystsCovering analysts | 5 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% |
| Dividend StreakConsecutive years of raises | — | 3 |
| Dividend / ShareAnnual DPS | — | $0.14 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.7% |
Insufficient data to determine a leader in this category.
Key Takeaway
GEHC leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NNOX leads in 1 (Valuation Metrics).
Best OverallGE HealthCare Technologies … (GEHC)Leads 4 of 6 categories
Loading custom metrics...
NNOX vs GEHC: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is NNOX or GEHC a better buy right now?
For growth investors, Nano-X Imaging Ltd.
(NNOX) is the stronger pick with 13. 9% revenue growth year-over-year, versus 4. 8% for GE HealthCare Technologies Inc. (GEHC). GE HealthCare Technologies Inc. (GEHC) offers the better valuation at 13. 5x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate Nano-X Imaging Ltd. (NNOX) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NNOX or GEHC?
Over the past 5 years, GE HealthCare Technologies Inc.
(GEHC) delivered a total return of +2. 9%, compared to -93. 9% for Nano-X Imaging Ltd. (NNOX). Over 10 years, the gap is even starker: GEHC returned +2. 9% versus NNOX's -96. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NNOX or GEHC?
By beta (market sensitivity over 5 years), GE HealthCare Technologies Inc.
(GEHC) is the lower-risk stock at 1. 37β versus Nano-X Imaging Ltd. 's 1. 86β — meaning NNOX is approximately 36% more volatile than GEHC relative to the S&P 500. On balance sheet safety, Nano-X Imaging Ltd. (NNOX) carries a lower debt/equity ratio of 4% versus 94% for GE HealthCare Technologies Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — NNOX or GEHC?
By revenue growth (latest reported year), Nano-X Imaging Ltd.
(NNOX) is pulling ahead at 13. 9% versus 4. 8% for GE HealthCare Technologies Inc. (GEHC). On earnings-per-share growth, the picture is similar: Nano-X Imaging Ltd. grew EPS 15. 7% year-over-year, compared to 4. 8% for GE HealthCare Technologies Inc.. Over a 3-year CAGR, NNOX leads at 105. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — NNOX or GEHC?
GE HealthCare Technologies Inc.
(GEHC) is the more profitable company, earning 10. 1% net margin versus -474. 3% for Nano-X Imaging Ltd. — meaning it keeps 10. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEHC leads at 13. 4% versus -502. 9% for NNOX. At the gross margin level — before operating expenses — GEHC leads at 40. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is NNOX or GEHC more undervalued right now?
Analyst consensus price targets imply the most upside for NNOX: 922.
7% to $18. 00.
07Which pays a better dividend — NNOX or GEHC?
In this comparison, GEHC (0.
2% yield) pays a dividend. NNOX does not pay a meaningful dividend and should not be held primarily for income.
08Is NNOX or GEHC better for a retirement portfolio?
For long-horizon retirement investors, GE HealthCare Technologies Inc.
(GEHC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Nano-X Imaging Ltd. (NNOX) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GEHC: +2. 9%, NNOX: -96. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between NNOX and GEHC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NNOX is a small-cap quality compounder stock; GEHC is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(NNOX: 13.7% · GEHC: 7.4%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.